Beta

Latest News Earnings Earning Calendar Analyst Rating Pricing

Sarepta Therapeutics Inc. (SRPT): Jefferies reiterates Buy, PT at $30

SRPTSarepta Therapeutics Inc.•Jefferies•Sep 24, 2026

1

Terms & Conditions Privacy Policy Cookie Policy Disclaimer Contact

© 2026 Stockwhiz. All rights reserved.

Market information and AI summaries are provided for informational purposes only.